Pacific Biosciences of California PACB Gains Losses On Restructuring Of Debt
Gains Losses On Restructuring Of Debt at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:GainsLossesOnRestructuringOfDebt.
The official record: Pacific Biosciences of California’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's gains losses on restructuring of debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's gains losses on restructuring of debt?
- Pacific Biosciences of California (PACB) reported gains losses on restructuring of debt of $0 in Q4 2025.
- How has Pacific Biosciences of California's gains losses on restructuring of debt changed year-over-year?
- Pacific Biosciences of California's gains losses on restructuring of debt decreased by 100.0% year-over-year, from $38.6M to $0.
- What does gains losses on restructuring of debt mean?
- This captures the financial impact resulting from the modification or early retirement of debt obligations. It reflects gains or losses realized when the terms of debt are altered or when debt is extinguished before its scheduled maturity. This metric is used to evaluate the company's proactive management of its capital structure and interest expense obligations.